Assurance Alar Sensor for Anesthesia Approved by FDA to Market

Assurance Biosense was granted FDA 510(k) clearance to market its Alar Sensor, an anesthesia device used for monitoring oxygen saturation in arterial hemoglobin and pulse rate.

The device allows for continuous non-invasive monitoring and compatibility with other large monitoring devices. Assurance developed the Alar Sensor based on clinical data that showed central monitoring of pulse oximetry to be an improvement over peripheral sites, such as finger tips, according to the release.

More Articles on Anesthesia:
Anesthesiologist Dr. Brian Brown Treated Boston Marathon Bombing Victims at the Scene
MedWatch Updates 53 Drug Safety Labels
Teleflex Awards Anesthesia Supply Distribution Rights to HealthTrust

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars